Studies and Evidence

The magnitude of the epidemic wave that struck France and Europe in 2024 clearly highlighted the need for a simple and fast molecular tool for the diagnosis of whooping cough. The main cause of whooping cough is Bordetella pertussis although other Bordetella species can also cause infection We evaluated the performance of the automated qPCR Vivalytic Bordetella test (Bosch Healthcare Solutions GmbH, Germany) for the detection of Bordetella species outside its intended use, using additional sample types. The Vivalytic platform, with its intuitive cartridge system, is designed for application in laboratories and point of care settings ...

Learn more

Despite a high vaccination coverage in the EU, whooping cough is not only present in Europe, but is dramatically on the rise in the post-pandemic era. Several countries reported outbreaks or increasing numbers in 2023/24...

Learn more

Since the appearance of the virus SARS-CoV-2 in 2019, in Germany different testing strategies have emerged in order to meet the growing demand of available tests to avoid a further spreading of the disease.,,

Learn more

The ongoing pandemic of SARS-CoV-2 requires the availability of accurate and rapid diagnostic tests, especially in some clinical settings like emergency and intensive care units (ICU). The objective of this study was to validate the rapid PCR kit Vivalytic SARS-CoV-2 in lower respiratory tract (LRT) specimens.

Learn more

Clostridioides difficile (C. difficile) is a significant cause of healthcare-associated infections, leading to conditions ranging from mild diarrhea to severe colitis. Accurate and timely diagnosis of C. difficile infection (CDI) is critical for patient management and infection control. Traditional diagnostic methods face challenges...

Learn more

The Vivalytic Urinary tract infection (UTI) test, currently under development, represents a qualitative PCR-based microarray test able to detect twenty-one specific uropathogenic bacteria and seven associated antimicrobial resistance genes in a point-of-care (POC) setting in four steps within 146 minutes...

Learn more

In a comparative testing published by our distributor Aprimeo, the innovative Vivalytic system is compared with standard RT-PCR diagnostics. The study on screening for sexually transmitted infections (STI) was conducted in a fertility practice clinic in Hamburg ...

Learn more

M. genitalium (MG), M. hominis (MH), U. parvum (UP) or U. urealyticum (UU) are bacteria without a cell wall. They are either considered as pathogenic or commensal living organisms in the urogenital tract. They belong to the category of sexually transmitted infections in men and women ...

Learn more

C. auris is an emerging, multi-drug-resistant pathogen, implicated in hospital outbreaks. Colonization screening is a key strategy for transmission and outbreak prevention in healthcare facilities ...

Learn more

Candidozyma auris is a multidrug-resistant WHO designated critical priority pathogen since 2022 and can result in colonisation as well as invasive infections. Spread between patients usually occurs indirectly via contaminated equipment and the environment, where it can persist for prolonged periods of time and is relatively resistant to many cleaning agents ...

Learn more

Candidozyma auris (C. auris) is a multidrug-resistant fungal pathogen causing severe invasive infections with high transmission risk in healthcare settings. This study evaluates the performance of six commercial molecular assays (5 rtPCR, 1 LAMP), three solid media and compares two liquid media eSwab® and a novel selective broth, CABroth for clinical laboratory use ...

Learn More

Staphylococcus aureus infections are a leading cause of hospital morbidity and mortality, often resulting in prolonged stays and elevated healthcare costs ...

Learn more

Acute bacterial meningitis is a severe and rapidly progressing infection and is on a rise globally. The CDC reported a significant increase of the disease in the US in 2023/24 (e.g. Neisseria meningitidis Sg. Y) and WHO adopted a road map “Defeating meningitis by 2030”. The recent meningitis report of the Institut Pasteur (3^rd May 2024) stated that “rapid diagnosis is crucial” ...

Learn more

Point of care diagnostics has increased rapidly in recent years. Physicians and patients increasingly expect to obtain rapid, high-quality test results at bedside and at physician’s practices for immediate diagnosis and based upon the results, optimized patient treatment.

Learn more